Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Pustular Psoriasis Flare-Up in a Patient With Covid-19 Publisher Pubmed



Miladi R1 ; Janbakhsh A1 ; Babazadeh A2 ; Aryanian Z3 ; Ebrahimpour S2 ; Barary M4 ; Sio TT5 ; Wollina U6 ; Goldust M7 ; Mohseni Afshar Z1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
  2. 2. Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
  3. 3. Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Student Research Committee, Babol University of Medical Sciences, Babol, Iran
  5. 5. Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, United States
  6. 6. Department of Dermatology and Allergology, Stadtisches Klinikum Dresden, Academic Teaching Hospital of the Technical University of Dresden, Dresden, Germany
  7. 7. Department of Dermatology & Allergy, University Hospital Basel, Basel, Switzerland

Source: Journal of Cosmetic Dermatology Published:2021


Abstract

Introduction: The various cutaneous manifestations have lately appeared in the setting of COVID-19. Psoriasis flare-ups have been reported during a COVID-19 infection. Case presentation: We present a case of a 32-year-old woman with COVID-19 who presented with generalized pustular psoriasis. She received oral prednisolone, hydroxyzine, and topical clobetasol. The patient received follow-up two weeks later and found that her lesions were favorably desquamating. Methods: The PubMed, SCOPUS, and ISI Web of Science databases were thoroughly searched for English studies reporting psoriasis flare-ups following SARS-CoV-2 infection. Ten case reports/series were included after screening. Conclusions: Our case report brings awareness to clinicians for the possible cutaneous manifestation of COVID-19, which should be considered part of the differential diagnoses. © 2021 Wiley Periodicals LLC